Found 86 results
Author Title [ Type(Desc)] Year
Filters: Author is Hong M Moulton  [Clear All Filters]
Journal Article
H. Moulton, In vivo delivery of morpholino oligos by cell-penetrating peptides., Curr Pharm Des, vol. 19, no. 16, pp. 2963-9, 2013.
H. Moulton, In vivo delivery of morpholino oligos by cell-penetrating peptides., Current pharmaceutical design, vol. 19, no. 16, pp. 2963-9, 2013.
G. McClorey, Fall, A. M., Moulton, H., Iversen, P. L., Rasko, J. E., Ryan, M., Fletcher, S., and Wilton, S. D., Induced dystrophin exon skipping in human muscle explants., Neuromuscular disorders : NMD, vol. 16, no. 9-10, pp. 583-90, 2006.
B. W. Neuman, Stein, D. A., Kroeker, A. D., Moulton, H., Bestwick, R. K., Iversen, P. L., and Buchmeier, M. J., Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers., Advances in experimental medicine and biology, vol. 581, pp. 567-71, 2006.
B. W. Neuman, Stein, D. A., Kroeker, A. D., Churchill, M. J., Kim, A. M., Kuhn, P., Dawson, P., Moulton, H., Bestwick, R. K., Iversen, P. L., and Buchmeier, M. J., Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers., Journal of virology, vol. 79, no. 15, pp. 9665-76, 2005.
J. Yuan, Stein, D. A., Lim, T., Qiu, D., Coughlin, S., Liu, Z., Wang, Y., Blouch, R., Moulton, H., Iversen, P. L., and Yang, D., Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site., Journal of virology, vol. 80, no. 23, pp. 11510-9, 2006.
T. S. Deas, Binduga-Gajewska, I., Tilgner, M., Ren, P., Stein, D. A., Moulton, H., Iversen, P. L., Kauffman, E. B., Kramer, L. D., and Shi, P. Y., Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication., J Virol, vol. 79, no. 8, pp. 4599-609, 2005.
B. L. Geller, Deere, J. D., Stein, D. A., Kroeker, A. D., Moulton, H., and Iversen, P. L., Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers., Antimicrobial agents and chemotherapy, vol. 47, no. 10, pp. 3233-9, 2003.
M. Alonso, Stein, D. A., Thomann, E., Moulton, H., Leong, J. C., Iversen, P., and Mourich, D. V., Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers., Journal of fish diseases, vol. 28, no. 7, pp. 399-410, 2005.
Y. - J. Zhang, Wang, K. - Y., Stein, D. A., Patel, D., Watkins, R., Moulton, H., Iversen, P. L., and Matson, D. O., Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers., Antiviral research, vol. 73, no. 1, pp. 12-23, 2007.
K. Rosenke, Leventhal, S., Moulton, H., Hatlevig, S., Hawman, D., Feldmann, H., and Stein, D. A., Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino-oligomers., bioRxiv, 2020.
N. Jearawiriyapaisarn, Moulton, H., Sazani, P., Kole, R., and Willis, M. S., Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers., Cardiovascular research, vol. 85, no. 3, pp. 444-53, 2010.
N. Jearawiriyapaisarn, Moulton, H., Sazani, P., Kole, R., and Willis, M. S., Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers., Cardiovasc Res, vol. 85, no. 3, pp. 444-53, 2010.
B. Wu, Lu, P., Cloer, C., Shaban, M., Grewal, S., Milazi, S., Shah, S. N., Moulton, H., and Lu, Q. Long, Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino., The American journal of pathology, vol. 181, no. 2, pp. 392-400, 2012.
B. Wu, Lu, P., Cloer, C., Shaban, M., Grewal, S., Milazi, S., Shah, S. N., Moulton, H., and Lu, Q. Long, Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino., Am J Pathol, vol. 181, no. 2, pp. 392-400, 2012.
S. Tripathi, Pohl, M. O., Zhou, Y., Rodriguez-Frandsen, A., Wang, G., Stein, D. A., Moulton, H., DeJesus, P., Che, J., Mulder, L. C. F., Yángüez, E., Andenmatten, D., Pache, L., Manicassamy, B., Albrecht, R. A., Gonzalez, M. G., Nguyen, Q., Brass, A., Elledge, S., White, M., Shapira, S., Hacohen, N., Karlas, A., Meyer, T. F., Shales, M., Gatorano, A., Johnson, J. R., Jang, G., Johnson, T., Verschueren, E., Sanders, D., Krogan, N., Shaw, M., König, R., Stertz, S., García-Sastre, A., and Chanda, S. K., Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding., Cell Host Microbe, vol. 18, no. 6, pp. 723-35, 2015.
P. L. Iversen, Mourich, D. V., and Moulton, H., Monoclonal antibodies to two epitopes of beta-human chorionic gonadotropin for the treatment of cancer., Current opinion in molecular therapeutics, vol. 5, no. 2, pp. 156-60, 2003.
S. Fletcher, Honeyman, K., Fall, A. M., Harding, P. L., Johnsen, R. D., Steinhaus, J. P., Moulton, H., Iversen, P. L., and Wilton, S. D., Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse., Molecular therapy : the journal of the American Society of Gene Therapy, vol. 15, no. 9, pp. 1587-92, 2007.
H. Moulton and Moulton, J. D., Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy., Biochim Biophys Acta, vol. 1798, no. 12, pp. 2296-303, 2010.
H. Moulton and Moulton, J. D., Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy., Biochimica et biophysica acta, vol. 1798, no. 12, pp. 2296-303, 2010.
N. Ran, Lin, C., Leng, L., Han, G., Geng, M., Wu, Y., Bittner, S., Moulton, H., and Yin, H., MOTS-c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice., EMBO Mol Med, vol. 13, no. 2, p. e12993, 2021.
H. Moulton and Moulton, J. D., Peptide-assisted delivery of steric-blocking antisense oligomers., Current opinion in molecular therapeutics, vol. 5, no. 2, pp. 123-32, 2003.
S. Abes, Moulton, H., Turner, J., Clair, P., Richard, J. P., Iversen, P., Gait, M. J., and Lebleu, B., Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides., Biochemical Society transactions, vol. 35, no. Pt 1, pp. 53-5, 2007.
H. Moulton, Wu, B., Jearawiriyapaisarn, N., Sazani, P., Lu, Q. Long, and Kole, R., Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy., Annals of the New York Academy of Sciences, vol. 1175, pp. 55-60, 2009.
A. Amantana, Moulton, H., Cate, M. L., Reddy, M. T., Whitehead, T., Hassinger, J. N., Youngblood, D. S., and Iversen, P. L., Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate., Bioconjugate chemistry, vol. 18, no. 4, pp. 1325-31, 2007.

Pages